Daily dose of cholecalciferol per os — Competitive Intelligence Brief

Daily dose of cholecalciferol per os (Daily dose of cholecalciferol per os) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin D supplement. Area: Bone health, Immunology, Endocrinology.

phase 3 Vitamin D supplement Vitamin D receptor (VDR) Bone health, Immunology, Endocrinology Small molecule

Target snapshot

Daily dose of cholecalciferol per os (Daily dose of cholecalciferol per os) — Hospices Civils de Lyon. Cholecalciferol (vitamin D3) is converted in the body to its active form, calcitriol, which regulates calcium and phosphate homeostasis and modulates immune function.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Daily dose of cholecalciferol per os TARGET	Daily dose of cholecalciferol per os	Hospices Civils de Lyon	phase 3	Vitamin D supplement	Vitamin D receptor (VDR)
Ergocalciferol 50000 UNT	Ergocalciferol 50000 UNT	University of Alabama at Birmingham	marketed	Vitamin D supplement	Vitamin D receptor (VDR)
Vitamin D3 tablets	Vitamin D3 tablets	Ain Shams University	marketed	Vitamin D supplement / Secosteroid	Vitamin D receptor (VDR)
Cholecalciferol 12 000 UI	Cholecalciferol 12 000 UI	Assistance Publique - Hôpitaux de Paris	marketed	Vitamin D supplement	Vitamin D receptor (VDR)
Ergocalciferol (Vitamin D)	Ergocalciferol (Vitamin D)	Barts & The London NHS Trust	marketed	Vitamin D supplement	Vitamin D receptor (VDR)
Cholecalciferol (vitamin D)	Cholecalciferol (vitamin D)	University of Tromso	marketed	Vitamin D supplement / Secosteroid	Vitamin D receptor (VDR)
oral cholecalciferol + life style counselling	oral cholecalciferol + life style counselling	Post Graduate Institute of Medical Education and Research, Chandigarh	marketed	Vitamin D supplement	Vitamin D receptor (VDR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin D supplement class)

1. Hospices Civils de Lyon · 2 drugs in this class
2. Assistance Publique - Hôpitaux de Paris · 1 drug in this class
3. Atlanta VA Medical Center · 1 drug in this class
4. Barts & The London NHS Trust · 1 drug in this class
5. Centre of Postgraduate Medical Education · 1 drug in this class
6. Hospital Infantil de Mexico Federico Gomez · 1 drug in this class
7. Post Graduate Institute of Medical Education and Research, Chandigarh · 1 drug in this class
8. University Hospital, Tours · 1 drug in this class
9. University of Alabama at Birmingham · 1 drug in this class
10. Amgen · 1 drug in this class